584 related articles for article (PubMed ID: 25482636)
41. Differential expression of the receptor tyrosine kinase EphB4 and its ligand Ephrin-B2 during human placental development.
Chennakesava CS; Di Santo S; Ziemiecki A; Schneider H; Andres AC
Placenta; 2006; 27(9-10):959-67. PubMed ID: 16343615
[TBL] [Abstract][Full Text] [Related]
42. Roles of ephrinB ligands and EphB receptors in cardiovascular development: demarcation of arterial/venous domains, vascular morphogenesis, and sprouting angiogenesis.
Adams RH; Wilkinson GA; Weiss C; Diella F; Gale NW; Deutsch U; Risau W; Klein R
Genes Dev; 1999 Feb; 13(3):295-306. PubMed ID: 9990854
[TBL] [Abstract][Full Text] [Related]
43. Arterial-venous segregation by selective cell sprouting: an alternative mode of blood vessel formation.
Herbert SP; Huisken J; Kim TN; Feldman ME; Houseman BT; Wang RA; Shokat KM; Stainier DY
Science; 2009 Oct; 326(5950):294-8. PubMed ID: 19815777
[TBL] [Abstract][Full Text] [Related]
44. The role of ephrins-B1 and -B2 during fetal rat lung development.
Peixoto FO; Pereira-Terra P; Moura RS; Carvalho-Dias E; Correia-Pinto J; Nogueira-Silva C
Cell Physiol Biochem; 2015; 35(1):104-15. PubMed ID: 25547331
[TBL] [Abstract][Full Text] [Related]
45. The receptor tyrosine kinase EphB4 and ephrin-B ligands restrict angiogenic growth of embryonic veins in Xenopus laevis.
Helbling PM; Saulnier DM; Brändli AW
Development; 2000 Jan; 127(2):269-78. PubMed ID: 10603345
[TBL] [Abstract][Full Text] [Related]
46. EphrinB2/EphB4 Signaling Regulates DPSCs to Induce Sprouting Angiogenesis of Endothelial Cells.
Gong T; Xu J; Heng B; Qiu S; Yi B; Han Y; Lo ECM; Zhang C
J Dent Res; 2019 Jul; 98(7):803-812. PubMed ID: 31017515
[TBL] [Abstract][Full Text] [Related]
47. Altered expression patterns of EphrinB2 and EphB2 in human umbilical vessels and congenital venous malformations.
Diehl S; Bruno R; Wilkinson GA; Loose DA; Wilting J; Schweigerer L; Klein R
Pediatr Res; 2005 Apr; 57(4):537-44. PubMed ID: 15718372
[TBL] [Abstract][Full Text] [Related]
48. Ex vivo gene delivery of ephrin-B2 induces development of functional collateral vessels in a rabbit model of hind limb ischemia.
Katsu M; Koyama H; Maekawa H; Kurihara H; Uchida H; Hamada H
J Vasc Surg; 2009 Jan; 49(1):192-8. PubMed ID: 18950979
[TBL] [Abstract][Full Text] [Related]
49. PDGFRβ reverses EphB4 signaling in alveolar rhabdomyosarcoma.
Aslam MI; Abraham J; Mansoor A; Druker BJ; Tyner JW; Keller C
Proc Natl Acad Sci U S A; 2014 Apr; 111(17):6383-8. PubMed ID: 24733895
[TBL] [Abstract][Full Text] [Related]
50. EphB4 controls blood vascular morphogenesis during postnatal angiogenesis.
Erber R; Eichelsbacher U; Powajbo V; Korn T; Djonov V; Lin J; Hammes HP; Grobholz R; Ullrich A; Vajkoczy P
EMBO J; 2006 Feb; 25(3):628-41. PubMed ID: 16424904
[TBL] [Abstract][Full Text] [Related]
51. Emerging roles of the Angiopoietin-Tie and the ephrin-Eph systems as regulators of cell trafficking.
Pfaff D; Fiedler U; Augustin HG
J Leukoc Biol; 2006 Oct; 80(4):719-26. PubMed ID: 16864601
[TBL] [Abstract][Full Text] [Related]
52. Engineered fibrin matrices for functional display of cell membrane-bound growth factor-like activities: study of angiogenic signaling by ephrin-B2.
Zisch AH; Zeisberger SM; Ehrbar M; Djonov V; Weber CC; Ziemiecki A; Pasquale EB; Hubbell JA
Biomaterials; 2004 Jul; 25(16):3245-57. PubMed ID: 14980419
[TBL] [Abstract][Full Text] [Related]
53. PEGylation potentiates the effectiveness of an antagonistic peptide that targets the EphB4 receptor with nanomolar affinity.
Noberini R; Mitra S; Salvucci O; Valencia F; Duggineni S; Prigozhina N; Wei K; Tosato G; Huang Z; Pasquale EB
PLoS One; 2011; 6(12):e28611. PubMed ID: 22194865
[TBL] [Abstract][Full Text] [Related]
54. Symmetrical mutant phenotypes of the receptor EphB4 and its specific transmembrane ligand ephrin-B2 in cardiovascular development.
Gerety SS; Wang HU; Chen ZF; Anderson DJ
Mol Cell; 1999 Sep; 4(3):403-14. PubMed ID: 10518221
[TBL] [Abstract][Full Text] [Related]
55. Eph/ephrin molecules--a hub for signaling and endocytosis.
Pitulescu ME; Adams RH
Genes Dev; 2010 Nov; 24(22):2480-92. PubMed ID: 21078817
[TBL] [Abstract][Full Text] [Related]
56. Shb promotes blood vessel formation in embryoid bodies by augmenting vascular endothelial growth factor receptor-2 and platelet-derived growth factor receptor-beta signaling.
Rolny C; Lu L; Agren N; Nilsson I; Roe C; Webb GC; Welsh M
Exp Cell Res; 2005 Aug; 308(2):381-93. PubMed ID: 15919073
[TBL] [Abstract][Full Text] [Related]
57. Design, synthesis and characterization of novel small molecular inhibitors of ephrin-B2 binding to EphB4.
Duggineni S; Mitra S; Noberini R; Han X; Lin N; Xu Y; Tian W; An J; Pasquale EB; Huang Z
Biochem Pharmacol; 2013 Feb; 85(4):507-13. PubMed ID: 23253822
[TBL] [Abstract][Full Text] [Related]
58. Molecular identification of venous progenitors in the dorsal aorta reveals an aortic origin for the cardinal vein in mammals.
Lindskog H; Kim YH; Jelin EB; Kong Y; Guevara-Gallardo S; Kim TN; Wang RA
Development; 2014 Mar; 141(5):1120-8. PubMed ID: 24550118
[TBL] [Abstract][Full Text] [Related]
59. Molecular controls of lymphatic VEGFR3 signaling.
Deng Y; Zhang X; Simons M
Arterioscler Thromb Vasc Biol; 2015 Feb; 35(2):421-9. PubMed ID: 25524775
[TBL] [Abstract][Full Text] [Related]
60. Distinct roles of ephrin-B2 forward and EphB4 reverse signaling in endothelial cells.
Hamada K; Oike Y; Ito Y; Maekawa H; Miyata K; Shimomura T; Suda T
Arterioscler Thromb Vasc Biol; 2003 Feb; 23(2):190-7. PubMed ID: 12588758
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
